Strides Pharma Science P/B Ratio
Strides Pharma Science (STAR) P/B ratio is 3.42 (High), book value per share ₹337.83 vs Healthcare average P/B of -0.33 — High - Premium to book value, growth expectations or asset-light model. Compare with STAR fair value estimate to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
STAR P/B Ratio — Valuation Insights & Book Value Analysis
Strides Pharma Science price-to-book ratio interpretation, valuation status and historical context — current P/B 3.42 (High). For live price, earnings yield and the full fundamental profile, see STAR stock price BSE.
- Stock appears overvalued with PB of 3.42, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 30.2% above historical average
- Trading at premium to sector average PB of -0.33
Strides Pharma Science P/B Ratio Historical Trend
STAR annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View STAR 52-week performance for the annual high/low range and current price position.
STAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Strides Pharma Science annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 3.42 | ₹337.83 | ₹1154.40 | ₹3,108 | High |
| 2025 | 3.2 | ₹281.2 | ₹900.35 | ₹2,587 | High |
| 2024 | 2.93 | ₹225.22 | ₹659.40 | ₹2,072 | Moderate |
| 2023 | 2.4 | ₹241.44 | ₹580.10 | ₹2,173 | Moderate |
| 2022 | 1.18 | ₹264.78 | ₹312.60 | ₹2,383 | Moderate |
STAR vs Healthcare Peers — P/B Ratio Comparison
Strides Pharma Science P/B 3.42 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |